Colonic PolypLPS-IINCT03865537
Cold Snare Endoscopic Mucosal Resection Trial
A study testing Cold snare EMR, Hot snare EMR and Eleview injection in people with Colonic Polyp and Colonoscopy, run by White River Junction Veterans Affairs Medical Center at 1 site in United States.
Trial summary
This study compares different approaches to endoscopic mucosal resection (EMR) of large non-pedunculated colorectal polyps (≥20mm) in a 2 x 2 randomized design. The first randomization will assign half of patients to polyp resection with electrocautery ("hot" snare EMR) and half of patient to polyp resection without… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Colonic Polyp, Colonoscopy, Complication
- What is being tested?
- Cold snare EMR, Hot snare EMR and Eleview injection
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 990 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Oct 2019to Jan 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Any patient ≥18 who presents for a colonoscopy and who does not have criteria for exclusion
- Patients with a ≥20mm non-pedunculated colorectal polyp
Who cannot join
- Pedunculated polyps (as defined by Paris Classification type Ip)
- Suspected adenocarcinoma with deep submucosal invasion
- Patients with ulcerated depressed lesions (as defined by Paris Classification type III) or confirmed adenocarcinoma
- Patients with inflammatory bowel disease
- Patients who are receiving an emergency colonoscopy
- Poor general health (ASA class>3)
Show all 9Show fewer
- Patients with coagulopathy with an elevated INR ≥1.5, or platelets <50
- Inadequate bowel preparation (Boston Bowel Prep Scale, total score ≤2)
- Pregnancy
Trial locations and contacts
1 site in 1 country.
United States1 site
White River Junction VAMC
White River Junction, Vermont, 05009
About this study
Official title: Cold Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial
This study compares different approaches to endoscopic mucosal resection (EMR) of large non-pedunculated colorectal polyps (≥20mm) in a 2 x 2 randomized design. The first randomization will assign half of patients to polyp resection with electrocautery ("hot" snare EMR) and half of patient to polyp resection without electrocautery ("cold" snare EMR). The second randomization will assign half of patients to polyp removal using Eleview as the submucosal injection agent, and the other half using placebo (normal saline with methylene blue) as the submucosal injection agent.
Read the detailed description
Electrocautery, or hot snare resection has long been considered the standard approach to polyp resection. A major limitation is a 5 to 10% risk of major adverse events. Recent studies suggest that snare resection without electrocautery - so-called cold snare EMR - may be safer than hot snare EMR. The concern with cold snare resection is a potentially lower efficacy, because cold snare resection requires the removal of a large polyp in smaller and greater number of pieces than with hot snare resection. This may lengthen procedure time and increase the risk of incomplete resection.
Furthermore, there is uncertainty about the optimal injection solution for lifting of the polyp prior to resection. Normal saline with methylene blue as the contrast agent is frequently used, but is limited by fast dissipation of the polyp lift. Eleview is a newly approved viscous solution (that contains methylene blue), which provides a longer polyp lift than normal saline. It is unclear how these two solutions compare with respect to resection efficacy and safety.
- Conditions
- Colonic Polyp, Colonoscopy, Complication, Recurrence
- Being tested
- Cold snare EMR, Hot snare EMR, Eleview injection, Placebo injection
- Medical subject headings
- Colonic Polyps, Recurrence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cold snare EMRProcedure or surgery
Participants will have their large polyp removed without electrocautery
Hot snare EMRProcedure or surgery
Participants will have their large polyp removed with electrocautery
Eleview injectionProcedure or surgery
Participants will have their polyp submucosally injected with Eleview
Placebo injectionProcedure or surgery
Participants will have their polyp submucosally injected with placebo
| Study group | Role | What they receive |
|---|---|---|
| Cold snare & Eleview injection | Experimental | Polyp resection without electrocautery (cold snare EMR), and initial submucosal injection with Eleview Receives: Procedure: Cold snare EMR; Procedure: Eleview injection |
| Cold Snare & Placebo injection | Experimental | Polyp resection without electrocautery (cold snare EMR), and initial submucosal injection with Placebo Receives: Procedure: Cold snare EMR; Procedure: Placebo injection |
| Hot snare & Eleview injection | Active comparator | Polyp resection with electrocautery (hot snare EMR), and initial submucosal injection with Eleview Receives: Procedure: Hot snare EMR; Procedure: Eleview injection |
| Hot snare & Placebo injection | Active comparator | Polyp resection with electrocautery (hot snare EMR), and initial submucosal injection with Placebo Receives: Procedure: Hot snare EMR; Procedure: Placebo injection |
What is being measured
The primary outcome is the main question the study is designed to answer.
Severe Adverse Events
Aggregate of all severe adverse events that occur at the time of the colonoscopy with resection of the large polyp or following the procedure
Measured: up to 30 days following the procedure
Secondary outcomes (8)
Subcategories of severe adverse events
Bleeding, post-polypectomy syndrome, perforation, abdominal pain
Measured: during the procedure and up to 30 days following the procedure
Performance submucosal injectate
Injection performance
Measured: immediately following polyp resection during the colonoscopy
Volume of submucosal injectate
volume of injection
Measured: immediately following polyp resection during the colonoscopy
Efficacy of submucosal injectate
Sidney index
Measured: immediately following polyp resection during the colonoscopy
Completeness of polyp resection
Complete polyp removal is defined as removal of all visible polyp tissue at the end of the EMR, as assessed by the endoscopist.
Measured: immediately following polyp resection during the colonoscopy
Intraprocedural bleeding
bleeding that requires endoscopic intervention to stop the bleeding
Measured: at the time of polyp resection
Polyp recurrence
Presence of biopsy proven neoplastic polyp tissue at the EMR resection site at surveillance colonoscopy following complete polyp resection
Measured: at surveillance colonoscopies up to 5 years following the initial polyp resection
Crossover from cold to hot snare
Proportion of polyps in the cold snare group that could not be removed by cold snare and were removed by hot snare, categorized by size and morphology subtypes of polyps
Measured: at the time of polyp resection
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Mar 2019
- Study start1 Oct 2019
- Primary completion31 May 2024
- Study completionJan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Colonic PolypStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Model description
- 2 x 2 randomized trial. First randomization: Among half of patients with a large polyp will be removed by electrocautery ("hot") snare resection, and the other half will have their polyp removed by snare resection without electrocautery ("cold"). Second randomization: Among half of patients the large polyp will by lifted (submucosal injection before resection) with Eleview; among the other by Placebo (Normal Saline with Methylene Blue).
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 990 participants (actual)
Sponsor and investigators
- Lead sponsor
- White River Junction Veterans Affairs Medical Center
- Sponsor type
- US federal agency
- Collaborators
- Dartmouth College, Steris, Cosmo Pharmaceuticals
- Responsible party
- Principal investigator, Dr. Heiko Pohl, White River Junction Veterans Affairs Medical Center
- Investigators
- Heiko Pohl, MD, Study chair, White River Junction VAMC, Geisel School of Medicine at Dartmouth
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03865537
- Sponsor's protocol ID
- 119681
- Acronym
- LPS-II
- Status last verified
- Jun 2024
- First submitted
- 3 Mar 2019
- Last updated
- 21 Jun 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Pohl H, Rex DK, Barber J, Moyer MT, Elmunzer BJ, Rastogi A, Gordon SR, Zolotarevsky E, Levenick JM, Aslanian HR, Elatrache M, von Renteln D, Wallace MB, Brahmbhatt B, Keswani RN, Kumta NA, Pleskow DK, Smith ZL, Abu Ghanimeh MK, Simmer S, Sanaei O, Mackenzie TA, Piraka C. Cold snare endoscopic resection for large colon polyps: a randomised trial. Gut. 2025 Oct 8;74(11):1804-1813. doi: 10.1136/gutjnl-2025-335075.
PubMed 40393701Djinbachian R, von Renteln D. Thermal ablation of the resection base after endoscopic mucosal resection: a useful tool when perfect technique is not achievable. Gut. 2024 Sep 9;73(10):e19. doi: 10.1136/gutjnl-2023-331676. No abstract available.
PubMed 38191267
Study at a glance
From the registry record, last updated by the sponsor on 21 Jun 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cold Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial
- ClinicalTrials.gov ID
- NCT03865537
- Acronym / sponsor ID
- LPS-II / 119681
- Conditions
- Colonic Polyp, Colonoscopy, Complication, Recurrence
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 990 participants (actual)
- Lead sponsor
- White River Junction Veterans Affairs Medical CenterUS federal agency
- Collaborators
- Dartmouth College, Steris, Cosmo Pharmaceuticals
- Study start
- 1 Oct 2019 (actual)
- Primary completion
- 31 May 2024 (actual)
- Study completion
- Jan 2027 (estimated)
- First posted
- 7 Mar 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study compares different approaches to endoscopic mucosal resection (EMR) of large non-pedunculated colorectal polyps (≥20mm) in a 2 x 2 randomized design. The first randomization will assign half of patients to polyp resection with electrocautery ("hot" snare EMR) and half of patient to polyp resection without electrocautery ("cold" snare EMR). The second randomization will assign half of patients to polyp removal using Eleview as the submucosal injection agent, and the other half using placebo (normal saline with methylene blue) as the submucosal injection agent.
Detailed description
Electrocautery, or hot snare resection has long been considered the standard approach to polyp resection. A major limitation is a 5 to 10% risk of major adverse events. Recent studies suggest that snare resection without electrocautery - so-called cold snare EMR - may be safer than hot snare EMR. The concern with cold snare resection is a potentially lower efficacy, because cold snare resection requires the removal of a large polyp in smaller and greater number of pieces than with hot snare resection. This may lengthen procedure time and increase the risk of incomplete resection.
Furthermore, there is uncertainty about the optimal injection solution for lifting of the polyp prior to resection. Normal saline with methylene blue as the contrast agent is frequently used, but is limited by fast dissipation of the polyp lift. Eleview is a newly approved viscous solution (that contains methylene blue), which provides a longer polyp lift than normal saline. It is unclear how these two solutions compare with respect to resection efficacy and safety.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 4
- Model description
- 2 x 2 randomized trial. First randomization: Among half of patients with a large polyp will be removed by electrocautery ("hot") snare resection, and the other half will have their polyp removed by snare resection without electrocautery ("cold"). Second randomization: Among half of patients the large polyp will by lifted (submucosal injection before resection) with Eleview; among the other by Placebo (Normal Saline with Methylene Blue).
| Arm | Type | Receives |
|---|---|---|
| Cold snare & Eleview injection | Experimental | Procedure: Cold snare EMR, Procedure: Eleview injectionPolyp resection without electrocautery (cold snare EMR), and initial submucosal injection with Eleview |
| Cold Snare & Placebo injection | Experimental | Procedure: Cold snare EMR, Procedure: Placebo injectionPolyp resection without electrocautery (cold snare EMR), and initial submucosal injection with Placebo |
| Hot snare & Eleview injection | Active comparator | Procedure: Hot snare EMR, Procedure: Eleview injectionPolyp resection with electrocautery (hot snare EMR), and initial submucosal injection with Eleview |
| Hot snare & Placebo injection | Active comparator | Procedure: Hot snare EMR, Procedure: Placebo injectionPolyp resection with electrocautery (hot snare EMR), and initial submucosal injection with Placebo |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Any patient ≥18 who presents for a colonoscopy and who does not have criteria for exclusion
- Patients with a ≥20mm non-pedunculated colorectal polyp
Key exclusion criteria (9 listed)
- Pedunculated polyps (as defined by Paris Classification type Ip)
- Suspected adenocarcinoma with deep submucosal invasion
- Patients with ulcerated depressed lesions (as defined by Paris Classification type III) or confirmed adenocarcinoma
- Patients with inflammatory bowel disease
- Patients who are receiving an emergency colonoscopy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cold snare EMRParticipants will have their large polyp removed without electrocautery | Procedure or surgery | Cold Snare & Placebo injection, Cold snare & Eleview injection |
| Hot snare EMRParticipants will have their large polyp removed with electrocautery | Procedure or surgery | Hot snare & Eleview injection, Hot snare & Placebo injection |
| Eleview injectionParticipants will have their polyp submucosally injected with Eleview | Procedure or surgery | Cold snare & Eleview injection, Hot snare & Eleview injection |
| Placebo injectionParticipants will have their polyp submucosally injected with placebo | Procedure or surgery | Cold Snare & Placebo injection, Hot snare & Placebo injection |
Primary outcome
Severe Adverse Events
Time frame: up to 30 days following the procedure
Aggregate of all severe adverse events that occur at the time of the colonoscopy with resection of the large polyp or following the procedure
8 secondary outcomes
Subcategories of severe adverse events
Time frame: during the procedure and up to 30 days following the procedure
Performance submucosal injectate
Time frame: immediately following polyp resection during the colonoscopy
Volume of submucosal injectate
Time frame: immediately following polyp resection during the colonoscopy
Efficacy of submucosal injectate
Time frame: immediately following polyp resection during the colonoscopy
Completeness of polyp resection
Time frame: immediately following polyp resection during the colonoscopy
Intraprocedural bleeding
Time frame: at the time of polyp resection
Polyp recurrence
Time frame: at surveillance colonoscopies up to 5 years following the initial polyp resection
Crossover from cold to hot snare
Time frame: at the time of polyp resection
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jun 2024.
- Derived from this study: PubMed 40393701Pohl H, Rex DK, Barber J, Moyer MT, Elmunzer BJ, Rastogi A, Gordon SR, Zolotarevsky E, Levenick JM, Aslanian HR, Elatrache M, von Renteln D, Wallace MB, Brahmbhatt B, Keswani RN, Kumta NA, Pleskow DK, Smith ZL, Abu Ghanimeh MK, Simmer S, Sanaei O, Mackenzie TA, Piraka C. Cold snare endoscopic resection for large colon polyps: a randomised trial. Gut. 2025 Oct 8;74(11):1804-1813. doi: 10.1136/gutjnl-2025-335075.
- Derived from this study: PubMed 38191267Djinbachian R, von Renteln D. Thermal ablation of the resection base after endoscopic mucosal resection: a useful tool when perfect technique is not achievable. Gut. 2024 Sep 9;73(10):e19. doi: 10.1136/gutjnl-2023-331676. No abstract available.
Related trials for Colonic Polyp
Enrolling by invitation
Cold Snare Piecemeal Resection vs Cold Snare Endoscopic Mucosal Resection
Colon Polyp, Colon Adenoma
Enrolling by invitation
Six Versus Twelve Month Index Follow-up After Large Colon Polyp Resection
Colon Polyp, Adenoma
Active, not recruiting
Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy
Colon Cancer, Colon Polyp
Recruiting
Comparison of Adenoma Detection Rate in 3D vs. 2D Surveillance Colonoscopy
Colonoscopy, Adenoma Detection Rate
Not yet recruiting
Right Colon Enema to Improve Bowel Preparation Quality During Colonoscopy
Colonic Polyps, Colorectal Neoplasms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Heiko Pohl, MD study chair
White River Junction VAMC, Geisel School of Medicine at Dartmouth
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cold snare EMR, Hot snare EMR and Eleview injection in people with Colonic Polyp and Colonoscopy, run by White River Junction Veterans Affairs Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 21 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Severe Adverse Events (time frame: up to 30 days following the procedure). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03865537, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2024; AzTrials last refreshed its copy on 27 Oct 2026.